is bpc 157 risks Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing what are the risks of

Metformin's insulin-sensitising effects complement the insulin-secreting properties of GLP-1 receptor agonists , whilst the appetite suppression and gastric effects of the injections enhance the modest weight benefits of metformin

Why animal studies are often poor predictors of human reactions to exposure

Amylin is a 37-amino acid peptide hormone co-secreted with insulin from pancreatic beta cells

Mumtaz et al., 2022)

Patent pending

I kept notes and found to back up telling the doctor that symptoms (headaches, loss of feeling in legs, wrists giving way and increasing anxiety) were all better after an injection but then increased from about 6 weeks